Impaired hypertension control in France: What the nephrologist needs to know

被引:0
|
作者
Rubin, Sebastien [1 ,2 ]
Boulestreau, Romain [3 ]
Couffinhal, Thierry [2 ,4 ]
Combe, Christian [1 ,5 ]
Girerd, Xavier [6 ]
机构
[1] CHU Bordeaux, Serv Nephrol Transplantat Renale Dialyse & Aphere, Hop Pellegrin, Pl Amelie Raba Leon, F-33076 Bordeaux, France
[2] Univ Bordeaux, Unite Inserm U1034, Bordeaux, France
[3] Hop Pau, Serv Cardiol & Hypertens Arterielle, 4 Blvd Hauter, F-64064 Pau, France
[4] CHU Bordeaux, Serv Cardiol, Hop Haut Leveque, Ave Magellan, F-33604 Pessac, France
[5] Univ Bordeaux, Unite Inserm, U1026 BioTis, Bordeaux, France
[6] Fdn Rech Hypertens Arterielle, 12 Rue Colonnes Trone, F-75012 Paris, France
来源
NEPHROLOGIE & THERAPEUTIQUE | 2020年 / 16卷 / 06期
关键词
Cardiovascular risk; Chronic kidney disease; Epidemiology; Hypertension; Prevention; BLOOD-PRESSURE CONTROL; TRIAL; RESTRICTION; COMBINATION; PROGRESSION; PREVALENCE; TARGETS; DISEASE; WOMEN; MEN;
D O I
10.1016/j.nephro.2020.10.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In France, 1 adult out of 3 is affected by hypertension and only 1 hypertensive out of 4 achieves blood pressure targets (<140/90 mmHg). This proportion is significantly better in similar countries (e.g. England, Germany, the USA). Nephrologists are particularly concerned since although more than 90 % of Chronic Kidney Disease (CKD) stages 3 and 4 patients are hypertensive, the CKD-REIN cohort shows that in France more than 1 out of 2 patients with CKD remains with a blood pressure above 140/90 mmHg. This report, based on the latest French studies and surveys, raises an important warning about the situation in France, discusses the main reasons for these results and offers some suggestions for improvement. Otherwise we risk a dramatic increase in the incidence of myocardial infarction, stroke, dependency and dementia in the coming years. (C) 2020 Societe francophone de nephrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 50 条
  • [1] Complement and the kidney: What the nephrologist needs to know in 2006?
    Berger, SP
    Roos, A
    Daha, MR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (12) : 2613 - 2619
  • [2] What every nephrologist needs to know about hydroxychloroquine toxicity
    Ayoub, Isabelle
    Singh, Priyamvada
    Ardoin, Stacy
    Brodsky, Sergey
    Hebert, Lee
    CLINICAL NEPHROLOGY, 2020, 93 (03) : 149 - 151
  • [3] What the non-nephrologist needs to know about dialysis
    Foy, Matt
    Sperati, C. John
    SEMINARS IN DIALYSIS, 2018, 31 (02) : 183 - 192
  • [4] Medicare from A to D: What every nephrologist needs to know
    Morrison, Lisa
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (03): : 899 - 904
  • [5] Extracorporeal Membrane Oxygenation-What the Nephrologist Needs to Know
    Razo-Vazquez, Andres Oswaldo
    Thornton, Kevin
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2016, 23 (03) : 146 - 151
  • [6] What a Nephrologist Needs to Know About Acute Liver Failure
    Leventhal, Thomas M.
    Liu, Kathleen D.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2015, 22 (05) : 376 - 381
  • [7] Rituximab for immunologic renal disease: What the nephrologist needs to know
    Kronbichler, Andreas
    Windpessl, Martin
    Pieringer, Herwig
    Jayne, David R. W.
    AUTOIMMUNITY REVIEWS, 2017, 16 (06) : 633 - 643
  • [8] Interventional Nephrology: What the Nephrologist Needs to Know about Vascular Access
    Chan, Micah R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (07): : 1211 - 1212
  • [9] Stent use for hemodialysis access: What a general nephrologist needs to know
    Anwar, Siddiq
    Vachharajani, Tushar J.
    HEMODIALYSIS INTERNATIONAL, 2018, 22 (02) : 143 - 149
  • [10] Type 2 Cardiorenal Sydrome In A Child: What The Nephrologist Needs To Know
    Melek, EngIn
    Aynaci, Sercan
    AtmiS, BahrIye
    Erdem, Sevcan
    Ozbarlas, Nazan
    Bayazit, Aysun Karabay
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1808 - 1809